Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) Return on Sales (2020 - 2025)

Bioventus (BVS) has disclosed Return on Sales for 5 consecutive years, with 0.11% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales changed N/A year-over-year to 0.11%, compared with a TTM value of 0.05% through Dec 2025, changed N/A, and an annual FY2025 reading of 0.05%, changed N/A over the prior year.
  • Return on Sales was 0.11% for Q4 2025 at Bioventus, up from 0.03% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.3% in Q2 2021 and bottomed at 0.63% in Q2 2023.
  • Average Return on Sales over 4 years is 0.09%, with a median of 0.02% recorded in 2021.
  • The sharpest move saw Return on Sales rose 17bps in 2021, then crashed -62bps in 2023.
  • Year by year, Return on Sales stood at 0.0% in 2021, then crashed by -96890bps to 0.19% in 2022, then increased by 22bps to 0.15% in 2023, then skyrocketed by 175bps to 0.11% in 2025.
  • Business Quant data shows Return on Sales for BVS at 0.11% in Q4 2025, 0.03% in Q3 2025, and 0.06% in Q2 2025.